To study the molecular mechanisms associated with resistance to EGFR & ALK inhibitors in patients with unrespectable/metastatic non-squamous Non-Small Cell Lung Cancer (ns-NSCLC) | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

To study the molecular mechanisms associated with resistance to EGFR & ALK inhibitors in patients with unrespectable/metastatic non-squamous Non-Small Cell Lung Cancer (ns-NSCLC)

Implementing Organization

Principal Investigator

Dr. N. Singh Postgraduate Institute of Medical Education & Research Chandigarh

Related Research

Quick Information

Area of Research

Mathematical Sciences

Focus Area

Medical Research

Start Year

2020

End Year

2021

Duration

24

Sanction Amount

₹ 31.12 L

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…